Sowell Financial Services LLC Galapagos Nv Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$68.86 - $83.34 $5,439 - $6,583	-79 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$76.15 - $111.94 $533 - $783	-7 Reduced 8.14%	79 $6,000
Q4 2020 Jan 13, 2021	SELL	$96.85 - $148.25 $1,549 - $2,372	-16 Reduced 15.69%	86 $9,000
Q3 2020 Nov 12, 2020	SELL	$122.47 - $213.56 $10,165 - $17,725	-83 Reduced 44.86%	102 $14,000
Q2 2020 Aug 13, 2020	SELL	$185.52 - $231.25 $65,303 - $81,400	-352 Reduced 65.55%	185 $36,000
Q1 2020 May 12, 2020	BUY	$143.0 - $274.03 $62,491 - $119,751	437 Added 437.0%	537 $105,000
Q4 2019 Feb 07, 2020	SELL	$146.12 - $215.82 $2,191 - $3,237	-15 Reduced 13.04%	100 $20,000
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $15,000 - $21,578	115 New	115 $18,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.85B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.